Back in April, we at the Prescription Access Litigation (PAL) blog asked “What is Abbott trying to hide?” in a blog post about drugmaker Abbott Laboratories’ efforts to keep documents from reaching the public in a class action lawsuit challenging Abbott’s unconscionable 400% price hike for its HIV/AIDS drug Norvir.
I’m pleased to report that the Court in that case recently ordered that some of the documents be made available to the public.
PAL have just posted those documents in their entirety on the PAL blog, in an entry titled “What Abbott was Trying to Hide - Court unseals Norvir documents.”
No comments:
Post a Comment